INPATIENT VS. OUTPATIENT: A COST COMPARISON OF THE USE OF LOW MOLECULAR WEIGHT HEPARINS DURING PREGNANCY

Sihana Ahmeti Lika, Dorentina Bexheti, Veton Ademi, Edita Alili Idrizi, Ledjan Malaj

Abstract

Introduction: LMWH have been shown to be effective and safe in the treatment of deep vein thrombosis. To our knowledge, this is the first analysis conducted in the Republic of Macedonia. There have been no direct comparisonsof such treatment on an outpatient versus an inpatient basis. Aim: The aim of this study is to verify the accurate cost paid by the Health Insurance Fund of Macedonia (HIFM) for the years 2014-2015 (there has beencomparisons of inpatient treatment for the years 2012-2013 and outpatient treatment for the years 2014-2015) due to the fact that the HIFM changed its prescription method for these medications. Material and Methods:For the years 2012-2013 there has been retrospective analysis, while for the years 2014-2015 a prospective cohort study has been conducted. The data was taken from the hospital’s archive and it was approved by the institution’s managing board. Results:The change from inptatient to outpatietn treatment for the years 2012-2013 would save 2,139,847.00 Macedonian Denars / 34,794.26 Euros to the HIFM, while for the years 2014-2015 the total saved is 2,528,820.00 Macedonian Denars / 41,119.00 Euros. (1 Euro equals 60.15 Macedonian Denars) Conclusion:the ammendment of the medications law was financially beneficial for the HIFM.

Pages: 57 - 64